BTOG - British Thoracic Oncology Group

This first-in-a-series BTOG Webcast includes an introduction from Cecilia Pompili and then Allan Hackshaw looks at what training and support a patient advocate could be offered when they take part in the development of research proposals.  The webcast concludes with a “fireside chat” with Sally Hall who is an established patient advocate.  The role of a patient advocate in research is often referr...

In this BTOG podcast, Dr Tom Newsom-Davis, Chair of BTOG and Consultant Thoracic Medical Oncologist at Chelsea and Westminster Hospital, is joined by Dr Joanne Evans, Consultant in Medical Oncology at Imperial College Healthcare NHS Trust, and Adam Januszewski, Consultant Medical Oncologist at St Bartholomew’s Hospital, to discuss key lung cancer highlights from ASCO 2026. The panel reviews major...

In this BTOG webcast and podcast, Dr Clive Peedell is joinedby Dr John Conibear and Rebecca Pickles to discuss key thoracic oncology highlights from ESTRO 2026. The conversation covers single-fraction SABR for early-stagelung cancer, radiotherapy and immunotherapy sequencing, approaches for frailer patients with stage III disease, palliative and consolidative radiotherapy in stage IV disease, and...

BTOG Steering Committee Members, Tanya Patrick and Neal Navani have reviewed the new 9th Edition TNM Lung Cancer Classification and produced: Webcast running through TNM9 in detail A full presentation to accompany the webcast which you can use to present to your team A brief presentation highlighting what has changed which you can use to present to your team BTOG is hoping to receive a stock of th...

In this special BTOG podcast, we partner with the National Lung Cancer Audit (NLCA) to explore the latest State of the Nation data and what it means for lung cancer care across the UK. Host Tom Newsom-Davis is joined by leading experts including John Conibear, Douglas West, Lauren Dixon, and Sarah Cook to unpack the trends shaping modern practice—from the rise in early-stage diagnosis and expandin...

BTOG does Lung NETs: Hosted by Dr Emma O'Dowd, Prof Matt Evison and Prof Was Mansoor explain why we should move beyond “carcinoid,” how diagnosis and staging pathways differ from standard lung cancer, and what is needed to improve access, follow-up, and treatment options.

Join BTOG and the UKLCC to discuss the recent UKLCC conference “UK Lung Cancer: 20 years on – what’s next?”       Participants:   Dr Tom Newsom-Davis, Chair, BTOG Steering Committee and Consultant Thoracic Medical Oncologist at Chelsea and Westminster Hospital, London   Dr Emma O’Dowd, BTOG Steering Committee Member and Consultant Respiratory Physician/Honorary Associate Professor at Nottingham Un...

A look at the top 10 abstracts – the rationale and design, efficacy, side effects and potential impact with Dr Tom Newsom-Davis, Chair, BTOG and Consultant Thoracic Medical Oncologist at Chelsea and Westminster Hospital, London; Dr Shobhit Baijal, BTOG Steering Committee Member and Consultant Medical Oncologist, University Hospital Birmingham NHS Trust, Birmingham and; Dr Sharmistha Ghosh, Associa...

In this episode of the series, BTOG Steering Committee member, Dr Emma O’Dowd, Consultant Respiratory Physician/Honorary Associate Professor at Nottingham University Hospitals NHS Trust/University of Nottingham talk to Dr Clive Peedell, Consultant Clinical Oncologist, James Cook University Hospital.

In this episode of the series, BTOG Steering Committee Chair, Dr Tom Newsom-Davis, Consultant Thoracic Medical Oncologist at Chelsea and Westminster Hospital, London and BTOG Steering Committee member, Dr Emma O’Dowd, Consultant Respiratory Physician/Honorary Associate Professor at Nottingham University Hospitals NHS Trust/University of Nottingham talk to Dr Jason Adhikaree, Clinical Associate Pro...

In this episode of the series, BTOG Steering Committee Chair, Dr Tom Newsom-Davis, Consultant Thoracic Medical Oncologist at Chelsea and Westminster Hospital, London and BTOG Steering Committee member, Dr Emma O’Dowd, Consultant Respiratory Physician/Honorary Associate Professor at Nottingham University Hospitals NHS Trust/University of Nottingham talk to Miss Sofina Begum, Consultant Thoracic Sur...

BTOG Steering Committee Chair, Dr Tom Newsom-Davis, Consultant Thoracic Medical Oncologist at Chelsea and Westminster Hospital, London and BTOG Steering Committee member, Dr Emma O’Dowd, Consultant Respiratory Physician/Honorary Associate Professor at Nottingham University Hospitals NHS Trust/University of Nottingham talks to Dr Helen Liddicoat, Respiratory Physician from Dundee.  Helen is Broncho...

Key highlights from the 2025 ASCO Annual Meeting, held in Chicago. Our expert panel review the most practice-changing presentations in thoracic oncology and discuss their potential impact on clinical care in the UK. Topics include major advances in immunotherapy, precision medicine, radiotherapy trials, small cell lung cancer trials, liquid biopsy and supportive care — with a focus on what UK clin...

BTOG Steering Committee member, Dr Emma O’Dowd, Consultant Respiratory Physician/Honorary Associate Professor at Nottingham University Hospitals NHS Trust/University of Nottingham talks to Professor Sanjay Agrawal, Consultant in Respiratory & Intensive Care Medicine, University Hospitals of Leicester NHS Trust.  Sanjay is also National Speciality Advisor for Tobacco Dependency at NHS England a...

The National Lung Cancer Audit (NLCA), commissioned by the Healthcare Quality Improvement Partnership (HQIP), evaluates the care received by patients diagnosed with lung cancer in NHS hospitals within England and Wales. We aim to stimulate quality improvement activities and reduce variation in the care, treatment and outcomes of patients diagnosed with lung cancer.

Dr Tom Newsom-Davis, Consultant in Medical Oncology at Chelsea and Westminster Hospital and Dr Emma O’Dowd, Consultant Respiratory Physician/Honorary Associate Professor at Nottingham University Hospitals NHS Trust/University of Nottingham were joined by Dr Riyaz Shah, Consultant Medical Oncologist at the Kent Oncology Centre to talk about the HER2 Mutation. 

BTOG does … MET Podcast is now released – this is part 5 of a series looking at mutations in lung cancer – we have already looked at BRAF, KRAS, RET and ROS1. Recorded recently, Dr Tom Newsom-Davis, BTOG Steering Committee Chair-Elect discussed MET with Dr Alastair Greystoke, Senior Lecturer and Honorary Consultant in Medical Oncology at University of Newcastle upon Tyne.

Led by Tom Newsom-Davis, this webinar covered clinically impactful thoracic oncology highlights of both WCLC 2024 and ESMO 2024. WCLC 2024 Highlights - Martin Forster, Consultant Medical Oncologist and Associate Professor, University College Hospital ESMO 2024 Metastatic Disease Highlights - Meenali Chitnis, Consultant Medical Oncologist, Oxford Cancer & Haematology Centre ESMO 2024 Early and...

Led by Tom Newsom-Davis, this webinar covered clinically impactful thoracic oncology highlights of ASCO 2024 held May 31 - June 4 in Chicago. Broadcast live on Monday 17 June 2024 18.00-19.15 Targeted Therapies in Advanced Stage NSCLC Dr Louise Lim, Consultant Medical Oncologist, St Bartholomew's Hospital Immunotherapy in Advanced Stage NSCLC Dr Tom Newsom-Davis, Consultant in Medical Oncology, Ch...

Dr Tom Newsom-Davis, BTOG Steering Committee Vice-Chair and Chair Elect is joined for this podcast by clinical oncology colleagues, Professor Corinne Faivre-Finn, Professor of Thoracic Radiation Oncology, University of Manchester and Honorary Consultant Clinical Oncologist, The Christie NHS Foundation Trust and Dr Fiona McDonald, Consultant Clinical Oncologist, The Royal Marsden NHS Foundation Tru...

Chaired by Neal Navani, NLCA Senior Clinical Lead and BTOG Steering Committee Member, this webinar presented the NLCA State of the Nation Report 2024.

Following on from Professor Eric Lim’s presentation “MARS2: results and UK implications” at BTOG 2024, Dr Tom Newsom-Davis, BTOG Steering Committee Chair-Elect, discusses Mesothelioma and Surgery with Professor Eric Lim, Consultant Thoracic Surgeon, Royal Brompton Hospital and Professor of Thoracic Surgery, Imperial College London and Mr David Waller, Consultant Thoracic Surgeon at Barts Health NH...

Dr Tom Newsom-Davis, BTOG Steering Committee Vice-Chair talks to Professor Najib M Rahman, Professor of Respiratory Medicine, Director, Oxford Respiratory Trials Unit and Nuffield Department of Medicine, University of Oxford

Dr Tom Newsom-Davis, BTOG Steering Committee Vice-Chair talks to Dr Meenali Chitnis, Consultant Medical Oncologist at Oxford University Hospitals NHS Foundation Trust.

BTOG does ... RET  – this is part 3 of a series looking at mutations in lung cancer – we have already looked at BRAF and KRAS.  Dr Tom Newsom-Davis, BTOG Steering Committee Vice-Chair talks to Dr Nadza Tokaca, Consultant Medical Oncologist at the Royal Marsden Hospital.